Levocarnitine
Levocarnitine (L-carnitine) is a naturally occurring amino acid derivative synthesized in vivo from methionine and lysine, essential for normal fat utilization and energy metabolism. In veterinary medicine, it is primarily utilized as a nutraceutical adjunct for: * **Dilated Cardiomyopathy (DCM)** in dogs (especially American Cocker Spaniels and Boxers, where up to 90% may have a carnitine deficiency). * **Feline Hepatic Lipidosis**, where it facilitates hepatic lipid metabolism and clearance. * Protection against **doxorubicin-induced cardiomyopathy**. * Adjunctive treatment for **valproic acid toxicity**. **Clinical Pearl:** Only the L-isomer (levocarnitine) is biologically active and beneficial. Racemic mixtures containing D-carnitine must be avoided as they competitively inhibit L-carnitine uptake and can induce a deficiency.
กลไกการออกฤทธิ์: Levocarnitine acts as an essential cofactor for the **carnitine palmitoyltransferase (CPT)** system. It binds to long-chain free fatty acids in the cytosol, forming acylcarnitine, which is then transported across the inner mitochondrial membrane. Inside the mitochondria → the fatty acids undergo **beta-oxidation** → generating **ATP** (cellular energy). This mechanism is particularly crucial for the myocardium, which relies heavily on fatty acid oxidation for energy, and for the liver during states of lipid mobilization (e.g., feline hepatic lipidosis).
ขนาดยาตามชนิดสัตว์
- Adjunctive dietary therapy in cats with severe hepatic lipidosis · 250 mg PO once daily · PO · q24h · Use Carnitor; also supplement with taurine (250 mg once to twice daily), Vitamin E (10 Units/kg/day), water soluble vitamins and determine B12 status (treat while awaiting data at 1 mg/cat SC).
- Supplementation in cats with liver disease · 250-500 mg/day · PO · q24h
- Trial for treating canine dilated cardiomyopathy (large or giant breed dog) · 2 grams PO q8-12h · PO · q8-12h · Approximately 1 teaspoonful of pure powder
- Adjunctive therapy of dilated cardiomyopathy in American Cocker spaniels · 1 gram PO q8-12h · PO · q8-12h · Give with taurine. Approximately 1/2 teaspoonful.
- Severe myocardial failure in Boxers · 2-3 grams PO q12h · PO · q12h · 2-4 months · To determine if they respond
- Adjunctive treatment of American cocker spaniels with dilated cardiomyopathy · 1 g PO q12h · PO · q12h · Give with taurine 500 mg q12h PO
- Dilated cardiomyopathy in American Cocker spaniels · 1 g PO q8h · PO · q8h
- Dilated cardiomyopathy in Boxer dogs · 2 g PO q8h · PO · q8h
- Documented systemic carnitine deficiency · 50-100 mg/kg PO q8h · PO · q8h
- Myocardial carnitine deficiency only · 200 mg/kg PO q8h · PO · q8h
วิธีการให้ยา
ข้อห้ามใช้
- Use of D-carnitine or racemic (D,L) mixtures (competitively inhibits L-carnitine uptake)
อาการไม่พึงประสงค์
- Gastrointestinal upset (loose stools, diarrhea, nausea, vomiting) - usually mild and dose-dependent
- Increased body odor (reported in human patients)
อันตรกิริยาระหว่างยา
- Valproic acid · Patients receiving valproic acid may require higher dosages of levocarnitine due to drug-induced carnitine depletion.
การติดตาม
- Clinical efficacy (improvement in cardiac or hepatic signs)
- Periodic blood chemistries (recommended in humans, value in veterinary medicine is undetermined)
การได้รับยาเกินขนาด
Levocarnitine is a relatively safe drug. * **Minor overdoses**: Need only to be monitored. * **Massive overdoses**: Consider gut emptying (emesis or gastric lavage). Refer to a veterinary poison control center for more information.
ข้อมูลอ้างอิงยาของ VetSheet มีไว้สำหรับสัตวแพทย์ผู้มีใบอนุญาตเพื่อช่วยในการตัดสินใจทางคลินิก ไม่ใช่สิ่งทดแทนการวินิจฉัยของผู้เชี่ยวชาญหรือฉลากล่าสุดของผู้ผลิต